The Asia Pacific GLP-1 market is projected to witness the fastest growth during the forecast period, owing to the rapid rise in lifestyle-related diseases and improving healthcare access
Clinical data from the STEP 1 extension study show that most patients experience weight regain after discontinuation, with research indicating that on average, approximately two-thirds of lost weight returns within one year of stopping treatment
Patients receiving both semaglutide and anticoagulant therapy require comprehensive safety monitoring and patient education
The second component is liking, defined as the subjective pleasure or hedonic value associated with eating and influenced by flavor, prior experience, context, cognitive factors, and physiological state
Focus on lean proteins, soft textures, and smaller meals
These hidden fees significantly increase the true cost of care